Adventapharma Drug Patent Portfolio

Adventapharma owns 1 orange book drug protected by 3 US patents Given below is the list of Adventapharma's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11707443 Storage Stable Aqueous Parenteral Solutions Comprising Diclofenac 08 Dec, 2040
Active
US11850224 Storage Stable Aqueous Injectable Solution Comprising Diclofenac 10 Aug, 2038
Active
US11110073 Storage Stable Aqueous Injectable Solution Comprising Diclofenac 23 Mar, 2038
Active


Adventapharma's Family Patents


Family Patents



Adventapharma Drug List

Given below is the complete list of Adventapharma's drugs and the patents protecting them.


1. Zueino

Zueino is protected by 3 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11707443 Storage Stable Aqueous Parenteral Solutions Comprising Diclofenac 08 Dec, 2040
(14 years from now)
Active
US11850224 Storage Stable Aqueous Injectable Solution Comprising Diclofenac 10 Aug, 2038
(11 years from now)
Active
US11110073 Storage Stable Aqueous Injectable Solution Comprising Diclofenac 23 Mar, 2038
(11 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zueino's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List